Who are AVTE's key supply-chain partners?

Map Aerovate (AVTE)'s suppliers, customers, dependencies, and concentration risk.

What is AVTE's biggest supplier?

See Aerovate (AVTE) top suppliers, their share of cost of goods sold, and geographic concentration risk.

See Aerovate (AVTE) top customers, share of revenue, and end-market concentration risk.

$2.68

Last traded 2025-04-28 — delisted

NASDAQ · Healthcare · Biotechnology · $77.7M mcap · 341841 float · 2.34% daily turnover · Short 34% of daily vol

1 relationships

As Filer

counterparties named

As Counterparty

mentioned by others

2022-04-29

Earliest Filing

2022-04-29

Latest Filing

1 mentions

Other companies that named AVTE in their SEC 8-K filings.

Filed By	Relationship	Summary	Filing Date	SEC
JBIO Aerovate Therapeutics, Inc.	partner	Tenant in an office lease agreement	2022-04-29	View

Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR